Verapamil Hydrochloride
Product Images NDC 59923-606

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Verapamil Hydrochloride (NDC 59923-606). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Areva Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Box-label-2ml (Box Label 2ml)

Box-label-2ml (Box Label 2ml)
This is a product label for Verapamil HCI Injection USP, which is used intravenously. It contains information about the dosage, storage instructions, and manufacturer details. It also mentions protecting the product from light and discarding any unused portion.*
FDA Label Image

Box-label-4ml (Box Label 4ml)

Box-label-4ml (Box Label 4ml)
This is a description of Verapamil HCI Injection USP at a concentration of 2.5 mg/mL. It emphasizes protection from light and intravenous use only. Each mL contains verapamil hydrochloride and sodium chloride. The recommended usage is for slow intravenous injection over a minimum of two minutes. Proper storage conditions at 20° to 25°C are highlighted. The product is presented in 5 x 4 mL single-dose vials. Manufactured by Areva Pharmaceuticals Inc.*
FDA Label Image

Chemical Structure (Chemical Structure)

FDA Label Image

Container-label (Container Label)

FDA Label Image
FDA Label Image

Vial-label-2ml (Vial Label 2ml)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.